Related Experiment Video

Updated: Sep 14, 2026

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
08:44

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Published on: September 1, 2016

[Is drug therapy possible in the acute stage of a cerebral infarct?]

P J Koudstaal

    Tijdschrift Voor Gerontologie En Geriatrie
    |April 1, 1987
    PubMed

    Insights

    Current treatments for acute cerebral infarction lack proven efficacy. More rigorous clinical trials are needed to establish effective interventions for stroke patients.

    Area of Science:

    • Neurology
    • Clinical Medicine
    • Medical Research

    Background:

    • Acute cerebral infarction, commonly known as stroke, presents significant treatment challenges.
    • Existing therapeutic options for stroke have been evaluated over the past three decades.
    • The need for evidence-based treatments for acute cerebral infarction is critical.

    Purpose of the Study:

    • To review and assess the efficacy of treatments for acute cerebral infarction.
    • To evaluate the quality of existing clinical trials on stroke treatment.
    • To determine the current state of knowledge regarding acute cerebral infarction interventions.

    Main Methods:

    • Systematic review of clinical trials conducted over the last 30 years.
    • Assessment of studies based on fundamental clinical trial requirements, including sample size.
    • Analysis of reported therapeutic effects and inactivities in reviewed studies.

    Main Results:

    • Few clinical trials met the basic requirements for robust scientific evidence.
    • No study demonstrated a statistically significant therapeutic effect for any intervention.
    • The small sample sizes in most studies precluded establishing therapeutic inactivity.

    Conclusions:

    • Current scientific knowledge does not support any specific treatment for acute cerebral infarction.
    • Further well-designed, large-scale clinical trials are essential.
    • Definitive results from future research are required to guide clinical practice for stroke management.

    More Related Videos

    Optimized Management of Endovascular Treatment for Acute Ischemic Stroke09:21

    Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

    Published on: January 18, 2018

    Brain Infarct Segmentation and Registration on MRI or CT for Lesion-symptom Mapping10:25

    Brain Infarct Segmentation and Registration on MRI or CT for Lesion-symptom Mapping

    Published on: September 25, 2019

    Related Concept Videos

    Alzheimer's Disease: Treatment01:22

    Alzheimer's Disease: Treatment

    Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
    Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

    Cardiopulmonary Resuscitation IV: Pharmacological Management

    Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
    Ischemic Stroke l: Introduction01:15

    Ischemic Stroke l: Introduction

    Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
    Ischemic Stroke ll: Pathophysiology01:15

    Ischemic Stroke ll: Pathophysiology

    An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
    Transient Ischemic Attack l: Introduction01:26

    Transient Ischemic Attack l: Introduction

    A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...